EGF and pancreatic neoplasm: The co-expression of these EGF families of ligands and receptor tyrosine kinases suggests that an autocrine mechanism is operative in pancreatic cancer, thereby allowing autonomous activation of signalling pathways that manifests as an aggressive tumor phenotype.